Sign in with Google
bearish
Generic Drug Antitrust Inquiry: A Primer
319 Views14 Nov 2016 03:55
Recent news stories reporting looming criminal antitrust charges against certain generic drug companies (and possibly executives) are wighing on...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- Taiwan Top 50 ETF Rebalance: Elite Materials Added (But Bigger Sell Flows Elsewhere)
- Fuji Corp (7605 JP): Usami Koyu’s JPY2,830 Tender Offer Is Light but Done
- Berli Jucker (BJC TB) - Packaged Consumerism
- Last Week in Event SPACE: Toyota Indust. Great Eastern, Mayne Pharma, Shibaura Elect., New World
Top Unpaywalled Insights
More »- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- A Storm Will Follow the Lull17 Feb 2017
- Indictments Starting to Appear15 Dec 2016
- No Trump Cards for This Risk18 Nov 2016
- Generic Drug Antitrust Inquiry: A Primer14 Nov 2016
x